1. Characterization of organ-specific immunoliposomes for delivery of 3′,5′-O-dipalmitoyl-5-fluoro-2′-deoxyuridine in a mouse lung-metastasis model

   • Atsuhide Mori
   • Stephen J. Kennel
   • Leaf Huang

   Original Article Pages: 447 - 456

2. A pilot study of amiodarone with infusional doxorubicin or vinblastine in refractory breast cancer

   • Susan E. Bates
   • Beverly Meadows
   • Lori J. Elwood

   Original Article Pages: 457 - 463

3. The bioavailability and dose dependency of the deuterated anti-tumour agent 4,6-benzylidene-d ₁-d-glucose in mice and rats

   • Camilla Bruno Dunsæd
   • John Michael Dornish
   • Erik Olai Pettersen

   Original Article Pages: 464 - 470

4. Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin

   • Kathy S. Smith
   • Brian A. Folz
   • Bijoy K. Bhuyan

   Original Article Pages: 471 - 482

5. Clinical and pharmacology study of chloroquinoxaline sulfonamide given on a weekly schedule

   • James R. Rigas
   • Prudence A. Francis
   • Raymond P. Warrell Jr.

   Original Article Pages: 483 - 488

6. Synchronization of cells in the S phase of the cell cycle by 3′-azido-3′-deoxythymidine: implications for cell cytotoxicity

   • Bangaru Chandrasekaran
   • Timothy E. Kute
   • David S. Duch

   Original Article Pages: 489 - 495

7. A phase I study of recombinant human interferon alpha-2b combined with 5-fluorouracil and cisplatin in patients with advanced cancer

   • Marc Trudeau
   • Alex Zukiwski
   • Gerald Batist

   Original Article Pages: 496 - 500

8. Direct evaluation of intracellular accumulation of free and polymer-bound anthracyclines

   • Tatjana Bogush
   • Galina Smirnova
   • Jacques Robert

   Original Article Pages: 501 - 505

9. Continuous mitoxantrone infusion in pretreated epithelial ovarian cancer

   • M. O. Nicoletto
   • R. Padrini
   • M. V. Fiorentino

   Original Article Pages: 506 - 510

10. Synergistic interaction between cisplatin and tamoxifen delays the emergence of cisplatin resistance in head and neck cancer cell lines

    • Bunzo Nakata
    • Kathleen D. Albright
    • Gerrit Los

    Original Article Pages: 511 - 518

11. Effects of hexadecylphosphocholine on fatty acid metabolism: relation to cytotoxicity

    • Margarete Goppelt-Struebe
    • Isabel Winter

    Original Article Pages: 519 - 526

12. Phase II study of a new vinca alkaloid derivative, S12363, in advanced breast cancer

    • Antoine Adenis
    • Jean-Marc Pion
    • Jacques Bonneterre

    Clinical Trial Report Pages: 527 - 528

13. Determination of platinum in plasma of patients affected by inoperable lung carcinoma treated with radiotherapy and concurrent low-dose continuous infusion ofcis-dichlorodiammine platinum(II)

    • Franca Morazzoni
    • Carmen Canevali
    • Grabriella Giudice

    Short Communication Pages: 529 - 532

14. Lithium concentrations during cisplatin-based chemotherapy: evidence for renal interaction

    • François Vincent
    • Thierry Alain Bensousan
    • Bernard Leclercq

    Letter to the Editors/Reply Pages: 533 - 534

15. Lithium pharmacokinetics and cisplatin-based chemotherapy

    • J. H. Beijnen

    Letter to the Editors/Reply Pages: 534 - 534